In this interview, Michael Conte, MD, delves into the role of SPMs in treating vascular diseases. He highlights the potential of synthetic resolvin D1 analogues to improve the management of vascular injuries and control post-surgical inflammation. Dr. Conte also emphasizes the importance of future research on SPMs, particularly in enhancing surgical recovery and developing biomarkers to optimize treatment strategies before and after surgery.
Michael Conte, MD, is the Chief and Professor of Vascular Surgery at the University of California, San Francisco.
